XOMA Royalty (XOMA) Operating Income Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.48 Mn |
-60.60 Mn |
- |
63.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
63.86% |
| Dec 31, 2025 |
25.96% |
| Sep 30, 2025 |
32.75% |
| Jun 30, 2025 |
43.67% |
| Mar 31, 2025 |
69.52% |
| Dec 31, 2024 |
-30.82% |
| Sep 30, 2024 |
-67.22% |
| Jun 30, 2024 |
-48.72% |
| Mar 31, 2024 |
-2.91% |
| Dec 31, 2023 |
-41.53% |
| Sep 30, 2023 |
-29.11% |
| Jun 30, 2023 |
-23.65% |
| Mar 31, 2023 |
-21.89% |
| Dec 31, 2022 |
-15.78% |
| Sep 30, 2022 |
-52.01% |
| Jun 30, 2022 |
-0.39% |
| Mar 31, 2022 |
-45.28% |
| Dec 31, 2021 |
121.54% |
| Sep 30, 2021 |
14.26% |
| Jun 30, 2021 |
-0.81% |
